FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes

Journal of Investigative Dermatology

Volumn 113, Issue 1, 1999, Pages 111-116

  Alanko, Tuomo ^a   Rosenberg, Maria ^a   Saksela, Olli ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2;

ADULT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DERMIS; GROWTH REGULATION; HUMAN; HUMAN CELL; MELANOCYTE; NEVUS CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032775514     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00636.x     Document Type: Article

References (43)

1. Alanko T, Tienari J, Lelitonen E, Saksela O: FGF-2 inhibits apoptosis in human teratocarcinoma cells during differentiation on collagen substratum. Exp Cell Res 228:306-312, 1996
2. Arrese Estrada J, Pierard-Franchimont C, Pierard G: Histogenesis of recurrent nevus. Am J Dermatopathol 12:370-372, 1990
3. Aviezer D, Iozzo R, Noonan D, Yayon A: Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol Cell Biol 17:1938-1946, 1997
4. Baird A, Klagsbrun M: The fibroblast growth factor family. Cancer Cells 3:239-243, 1991
5. Barrett A, Raha A: The immunohistochemical identification of human oral mucosal melanocytes. Arch Oral Biology 42:77-81, 1997
6. Bono F, Rigon P, Lamarche I, Savo P, Salel V, Herbert J: Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells. Biochem J 326:661-668, 1997
7. Cory A: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-212, 1991
8. Dionne C, Crumley G, Bellot F, et al: Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9:2685-2692, 1990
9. Dotto G, Moellmann G, Ghosh S, Edwards M, Halaban R: Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 109:3115-3128, 1989
10. Easton D, Cox G, Macdonald A, Ponder B: Genetic susceptibility to naevi-a twin study. Br J Cancer 64:1164-1167, 1991
11. Gavrieli Y, Sherman Y, Ben-Sasson S: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
12. Goldgar D, Cannon-Albright L, Meyer L, Piepkorn M, Zone J, Skolnick. M: Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 83:1726-1733, 1991
13. Greene M: Genetics of cutaneous melanoma and nevi. Mayo Clin Proc 72:467-474, 1997
14. Halaban R: Growth factors and melanomas. Seminars Oncol 23:673 681, 1996
15. Halaban R, Langdon R, Birthall N, et al: Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytcs. J Cell Biol 107:1611-1619, 1988
16. Halaban R, Fan B, Alin J, Funasaka Y, Gitay-Goren H, Neufeld G: Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes. J Immunother 12:154-161, 1992
17. Hersey P: Ganglioside antigens in tissue sections of skin, naevi, and melanoma -implications for treatment of melanoma. Cancer Treatment Research 54:137-151, 1991
18. Hu D-N, McCormick S, Ritch R, Pelton-Hendon K: Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanoeytes. Invest Ophthalmol Vis Sci 34:2210-2219, 1993
19. Huang Y, Li J, Nicolaides A, Zhang W, Friedman-Kien A: Increased expression of fibroblast growth factors (FGFs) and their receptors by protamine and suramin on Kaposi's sarcoma-derived cells. Anticancer Res 13:887-890, 1993
20. Karsan A, Yee E, Poirier G, Zhou P, Craig R, Harlan J: Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 151:1775-1784, 1997
21. Klein S, Bikfalvi A, Birkenmeier T, Giancotti F, Rifkin D: Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem 271:22583-22590, 1996
22. Mignatti P, Rifkin D: Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 47:201-207, 1991
23. Miyamoto T, Leconte I, Swain J, Fox J: Autocrine FGF signaling is required for vascular smooth muscle cell survival in vitro. J Cell Physiol 177:58-67, 1998
24. Montgomery A, Reisfeld R, Cheresh D: Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three dimensional dermal collagen. Proc Natl Acad Sci USA 91:8856-8860, 1994
25. Newton-Bishop J, Bataille V, Pinney E, Bishop D: Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res 4:199-206, 1994
26. Piotrowicz R, Martin J, Dilman W, Levin E: The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J Biol Chem 272:7042-7047, 1997
27. Reed J, McNutt N, Albino A: Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Am J Pathol 144:329-336, 1994
28. Rieger E, Hofmann-Wellenhof R, Soyer H, Kofier R, Cerroni L, Smolle J, Kerl H: Comparison of proliferative activity as assessed by proliferating cell nuclear antigen. (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study. J Cutan Pathol 20:229-236, 1993
29. Saksela O, Rifkin D: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 110:767-775, 1990
30. Saksela O, Moscatelli D, Sommer A, Rifkin D: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107:743-751, 1988
31. Schwab M, Alitalo K, Varmus H, Bishop J, George D: A cellular oncogenene (e-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature 303:497-501, 1983
32. Scott G, Liang H: pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Exp Cell Res 219:197-203, 1995
33. Scott G, Stoler M, Sarkar S, Halaban R: Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J Invest Dermatol 96:318-322, 1991
34. Scott G, Cassidy L, Busacco A: Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism. J Invest Dermatol 108:147-153, 1997
35. Shaulian E, Resnitzky D, Shifinan O, Blandino G, Amsterdam A, Yayon A, Oren M: Induction of Mdm2 and enhancement of cell survival by bFGF. Oncogene 15:2717-2727, 1997
36. Sommer A, Brewer M, Thompson R, Moscatelli D, Presta M, Rifkin D: A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Comm 144:543-550, 1987
37. Stefansson K, Wollman R, Jerkovic M: S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol 106:261-268, 1982
38. Vlodavsky I, Folkman J, Sullivan R, Friedman R, Ishai-Michaeli R, Sasse J, Klagsbrun M; Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84:2292-2296, 1987
39. Wang Y, Becker D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growh. Nat Med 3:887-893, 1997
40. Wieder R, Wang H, Shirke S, et al: Low level expression of basic MF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15:41-60, 1997
41. Wilkie A, Morriss-Kay G, Jones E, Heath J: Functions of fibroblast growth factors and their receptor. Curr Biol 5:500-507, 1995
42. Yayon A, Ma Y, Safran M, Klagsbrun M, Halaban R: Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient MF receptor 1: evidence for the involvement of Sre-family kinases. Oncogene 14:2999-3009, 1997
43. Zhai S, Yaar M, Doyle S, Gilchrest B: Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell. Res 224:335-343, 1996